Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?

W (Wenxia) Chai; Ingrid Van den Berg - Garrelds; US (Udayasankar) Arulmani; RG (Regien) Schoemaker; Jos Lamers; AHJ Danser

doi:10.1038/sj.bjp.0706220

Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?

W (Wenxia) Chai, Ingrid Van den Berg - Garrelds, US (Udayasankar) Arulmani, RG (Regien) Schoemaker, Jos Lamers, AHJ Danser

Research output: Contribution to journal › Article › Academic › peer-review

46 Citations (Scopus)

Original language	English
Pages (from-to)	664-671
Number of pages	8
Journal	British Journal of Pharmacology
Volume	145
Issue number	5
DOIs	https://doi.org/10.1038/sj.bjp.0706220
Publication status	Published - 2005

Research programs

EMC COEUR-01-43-01

Access to Document

10.1038/sj.bjp.0706220

http://hdl.handle.net/1765/13783

Cite this

@article{78a732d4a5454566b56f98ced253a670,

title = "Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?",

author = "Chai, {W (Wenxia)} and {Van den Berg - Garrelds}, Ingrid and Arulmani, {US (Udayasankar)} and Schoemaker, {RG (Regien)} and Jos Lamers and AHJ Danser",

year = "2005",

doi = "10.1038/sj.bjp.0706220",

language = "English",

volume = "145",

pages = "664--671",

journal = "British Journal of Pharmacology",

issn = "0007-1188",